BOSTON — The first formal phase 1 study of mesenchymal stem cells for multiple sclerosis (MS) to be conducted in North America has shown no safety issues. "The goal was to show safety, feasibility and ...
West Palm Beach, Florida — In an interim analysis of an extension study, intrathecal injection of autologous bone marrow–derived mesenchymal stem cells (MSCs) has been associated with favorable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback